Two Sigma Advisers’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-601,617
Closed -$4.21M 1917
2025
Q4
$4.21M Sell
601,617
-838,000
-58% -$6.56M 0.01% 891
2025
Q3
$11.1M Sell
1,439,617
-1,400,394
-49% -$10.9M 0.02% 466
2025
Q2
$24.7M Buy
2,840,011
+5,600
+0.2% +$40.6K 0.05% 296
2025
Q1
$22.6M Buy
2,834,411
+575,700
+25% +$5.82M 0.05% 308
2024
Q4
$20.5M Buy
2,258,711
+1,537,094
+213% +$14.8M 0.05% 304
2024
Q3
$6.62M Sell
721,617
-401,000
-36% -$3.32M 0.02% 614
2024
Q2
$11M Sell
1,122,617
-654,200
-37% -$7.98M 0.02% 510
2024
Q1
$26.8M Buy
1,776,817
+1,577,833
+793% +$28.6M 0.06% 282
2023
Q4
$4.29M Buy
198,984
+95,386
+92% +$1.76M 0.01% 885
2023
Q3
$1.93M Sell
103,598
-1,338,713
-93% -$31.2M ﹤0.01% 1230
2023
Q2
$36.5M Sell
1,442,311
-717,700
-33% -$18.1M 0.09% 216
2023
Q1
$55.9M Buy
2,160,011
+590,600
+38% +$15.8M 0.14% 153
2022
Q4
$37.1M Sell
1,569,411
-92,300
-6% -$2.49M 0.1% 199
2022
Q3
$42.1M Buy
1,661,711
+528,100
+47% +$18.5M 0.12% 179
2022
Q2
$37.6M Buy
+1,133,611
New +$48.1M 0.11% 202
2021
Q1
Sell
-70,626
Closed -$14.1M 2718
2020
Q4
$14.1M Buy
70,626
+33,826
+92% +$6.88M 0.04% 450
2020
Q3
$8.07M Sell
36,800
-5,800
-14% -$1.23M 0.02% 602
2020
Q2
$8.13M Buy
42,600
+39,100
+1,117% +$6.85M 0.02% 625
2020
Q1
$543K Sell
3,500
-15,800
-82% -$1.84M ﹤0.01% 1770
2019
Q4
$1.62M Buy
+19,300
New +$1.47M ﹤0.01% 1336
2018
Q4
Sell
-8,900
Closed -$769K 2458
2018
Q3
$769K Buy
+8,900
New +$634K ﹤0.01% 1615

Other funds holding TDOC

Two Sigma Advisers's TDOC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Teladoc Health (TDOC) in Q1 2026, closing a stake of 601,617 shares — an estimated $4.21M sold.

Two Sigma Advisers first reported a position in TDOC in Q3 2018 and held it in 21 quarters. The position peaked at $55.9M in Q1 2023. 322 funds tracked by Wall St. Rank hold TDOC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Teladoc Health position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 601,617 Teladoc Health shares in Q1 2026, an estimated $4.21M.
  • Two Sigma Advisers first reported a position in Teladoc Health in Q3 2018 and held it in 21 quarters.
  • Two Sigma Advisers's Teladoc Health position peaked at $55.9M in Q1 2023.
  • 322 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.